Weight-loss drug manufacturer Novo Nordisk cuts 9000 jobs — and its profit forecast

New CEO Mike Doustdar is kitchen-sinking the costs of restructuring the company to focus on diabetes and anti-obesity drugs.
Source link
About the Author
Amit Nayak
Administrator
Welcome to Untold Theory, where innovation meets insight. We are dedicated to uncovering the hidden dimensions of technology, science, and the digital world. Our mission is to deliver 100% accurate content that keeps you ahead of the curve.we bring you the latest trends, deep dives into emerging technologies, and thought-provoking analyses—all designed to fuel your curiosity. Untold Theory is your go-to source for exploring the untold stories behind the world's most transformative ideas.Join us on this journey of discovery, where every article sheds light on the theories shaping our future.


